Saturday 17 October 2026 Export NVST’s income statement to Excel — free account

Envista Holdings Corporation

NVST Healthcare Medical Instruments & Supplies

Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024. In the quarter to June 2026, revenue grew 7.10%, EPS grew 106.3%, free cash flow grew 37.6% and total debt was flat, each against the same quarter a year earlier.

22.90 0.60 −2.55%

Follow NVST

Alert me

Market cap: $3.8B
P/E: 38.8×
Fwd P/E: 24.4×
Dividend yield: —
F-score: 7/9
Altman Z: 1.59
Beneish M: −2.50
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 0.51

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	1	—	—	—	—	—	1	—	—

Insider Ownership 3.11%

Capital & Financial Ratios $m

Market Cap 3,770.00

Revenue 2,856.50

Net Income 95.00

Free Cash Flow 249.00

Net Debt 310.70

Current Ratio 2.43

Debt/Equity 0.47

P/E ratio 38.81

Fwd P/E 24.40

P/S ratio 1.30

P/B ratio 1.21

Past 5Y EPS Growth 6.96%

This Y EPS Growth 28.63%

Next Y EPS Growth 8.49%

Next Y revenue growth 5.79%

Next 5Y EPS Growth 14.95%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 61.95%

10-year low 10-year high

P/S against its own 10 years 15.86%

10-year low 10-year high

P/B against its own 10 years 46.40%

10-year low 10-year high

EV/Sales against its own 10 years 12.13%

10-year low 10-year high

EV/FCF against its own 10 years 34.10%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2018	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	940	1,069	1,212	1,126
Receivables	408	363	430	437
Inventory	259	241	288	291
Other	—	—	—	—
	1,744	1,788	2,027	1,958

	2023	2024	2025	Q'26
Payables	180	175	192	190
ST’ Debt	115	116	—	—
Other	—	—	—	—
	781	879	853	807

Compound Annual Growth %

	10y	5y	3y
Sales	—	7.11%	1.91%
Cash Flow	—	(0.58%)	14.70%
Earnings	—	7.13%	(42.18%)
Book Value	—	(3.55%)	(9.62%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	706	731	—	—	—
’25	617	682	670	751	2,720
’24	624	633	601	653	2,511
’23	627	662	631	646	2,567
’22	631	646	631	661	2,569
’21	613	637	607	652	2,509
’20	547	362	547	473	1,929

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(3)	119	—	—	—
’25	0	89	79	108	276
’24	40	93	71	132	337
’23	3	75	96	102	276
’22	4	22	47	110	183
’21	17	121	88	136	362
’20	(62)	5	148	193	284

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(16)	105	—	—	—
’25	(5)	76	68	92	231
’24	29	86	63	124	303
’23	(14)	61	77	100	224
’22	(16)	10	21	95	110
’21	8	101	82	127	319
’20	(76)	(3)	135	186	242

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	0.23	0.33	—	—	—
’25	0.10	0.16	(0.18)	0.20	0.28
’24	0.14	(6.69)	0.05	0.01	(6.50)
’23	0.25	0.29	0.12	(1.27)	(0.60)
’22	0.42	0.26	0.27	0.42	1.37
’21	0.41	0.51	0.52	0.48	1.92
’20	(0.11)	(0.59)	0.22	0.64	0.20

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	25.65	10.08	32.14	31.67	20.00	15.15	14.22	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	30.80	33.88	46.88	52.03	43.29	25.64	22.68
People
People	Employees	—	—	12,800	12,500	12,400	11,200	12,700	12,800	12,300	12,000
	Revenue/emp, $m	0.00	0.00	0.22	0.18	0.16	0.22	0.20	0.20	0.20	0.23
Income, $m
Income, $m	Revenue	2,785	2,811	2,845	2,285	1,929	2,509	2,569	2,567	2,511	2,720
	Gross margin, %	57.92	57.68	56.31	59.05	54.68	56.86	57.41	56.13	54.68	54.67
	EBT	402	387	301	234	(20)	255	284	(55)	(1,085)	177
	EBT margin, %	14.43	13.76	10.59	10.23	(1.04)	10.14	11.05	(2.14)	(43.20)	6.52
	Net income	272	301	231	218	33	341	243	(100)	(1,119)	47
	Depreciation	127	121	130	168	177	175	166	167	159	155
Per share, $
Per share, $	Revenue	17.52	21.98	22.24	16.78	12.09	15.56	15.77	15.38	14.58	16.19
	Earnings	1.71	2.35	1.80	1.60	0.21	2.11	1.49	(0.60)	(6.50)	0.28
	Cash flow	2.62	2.81	3.13	2.92	1.78	2.24	1.12	1.65	1.95	1.64
	Capex	0.00	(0.38)	(0.56)	(0.56)	(0.27)	(0.27)	(0.44)	(0.31)	(0.20)	(0.27)
	Free cash flow	2.62	2.43	2.56	2.36	1.51	1.98	0.68	1.34	1.76	1.37
	Book value	0.00	0.00	37.74	26.01	23.31	25.17	25.83	25.01	17.04	18.49
	Shares, m	159	128	128	136	160	161	163	167	172	168
Valuation, ×
Valuation, ×	P/E	5.52	5.52	5.52	18.44	168.65	21.25	22.79	0.00	0.00	77.54
	P/S	0.00	0.00	0.00	1.77	2.79	2.90	2.15	1.57	1.32	1.34
	P/B	0.74	0.74	0.74	1.14	1.45	1.79	1.32	0.96	1.13	1.17
	EV/Sales	0.00	0.00	0.00	2.25	3.26	2.99	2.45	1.79	1.45	1.47
	EV/FCF	8.96	8.96	8.96	16.03	26.04	23.57	57.17	20.55	12.04	17.32
Cash, $m
Cash, $m	Operating cash flow	417	359	400	398	284	362	183	276	337	276
	Capex	(49)	(49)	(72)	(76)	(42)	(43)	(72)	(52)	(34)	(45)
	Free cash flow	417	310	328	321	242	319	110	224	303	231
Balance, $m
Balance, $m	Working capital	—	167	146	293	(94)	628	188	963	910	1,174
	Total debt	—	—	—	1,325	1,795	1,316	1,381	1,513	1,394	1,448
	Net debt	—	—	—	1,114	906	242	774	573	325	237
	Shareholders’ equity	—	—	4,826	3,543	3,721	4,058	4,207	4,174	2,935	3,106
Returns, %
Returns, %	ROA	0.00	5.09	7.90	3.63	0.51	5.06	3.69	(1.52)	(18.71)	0.85
	ROIC	—	0.00	3.86	3.16	0.59	4.45	4.01	0.41	(19.90)	4.04
	ROE	0.00	6.14	4.70	5.20	0.92	8.75	5.88	(2.39)	(31.47)	1.56

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
BLCO Bausch + Lomb Corporation	$6.0B	— (loss-making)	— (loss-making)	+9.08% (above 0%: growing)	n/m	+251.85% (above 0%: growing)	62.20%	5.95%	Compare
TFX Teleflex Incorporated	$5.4B	— (loss-making)	45.3×	+28.88% (above 0%: growing)	−17.33% (below 0%: shrinking)	+220.14% (above 0%: growing)	58.16%	12.77%	Compare
MMSI Merit Medical Systems, Inc.	$5.4B	36.4×	23.4×	+9.51% (above 0%: growing)	+18.18% (above 0%: growing)	−25.66% (below 0%: shrinking)	51.37%	14.42%	Compare
STVN Stevanato Group S.p.A.	$5.3B	33.8×	27.5×	+10.46% (above 0%: growing)	−25.00% (below 0%: shrinking)	−167.02% (below 0%: shrinking)	28.75%	12.93%	Compare
ICUI ICU Medical, Inc.	$4.2B	136×	49.5×	+0.51% (above 0%: growing)	−46.85% (below 0%: shrinking)	+655.98% (above 0%: growing)	42.61%	7.09%	Compare
NVST Envista Holdings Corporation	$3.8B	38.8×	24.4×	+7.10% (above 0%: growing)	+106.25% (above 0%: growing)	+37.57% (above 0%: growing)	55.72%	10.99%
PLSE Pulse Biosciences, Inc	$3.3B	— (loss-making)	— (loss-making)	+4,922.22% (above 0%: growing)	n/m	−45.39% (below 0%: shrinking)	37.10%	(5,823.04%)	Compare
WRBY Warby Parker Inc.	$3.0B	334×	122×	+9.81% (above 0%: growing)	n/m	−71.75% (below 0%: shrinking)	57.94%	1.34%	Compare
ATRC AtriCure, Inc.	$2.9B	259×	591×	+12.83% (above 0%: growing)	n/m	−2.79% (below 0%: shrinking)	77.23%	6.29%	Compare
Median of peers	$4.7B	136×	47.4×	+10.14%	−21.16%	−14.22%	54.66%	6.69%

All 55 Medical Instruments & Supplies stocks →

Envista Holdings Corporation (NVST) key facts

Strength: Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024.
Envista Holdings Corporation (NVST) is a Medical Instruments & Supplies company in the Healthcare sector, listed on the New York Stock Exchange.
Net income was $47.0 million, or $0.28 per share (basic), a net margin of 1.73%.
As of October 16, 2026, NVST traded at $22.90, a market capitalization of $3.8 billion.
At that price the stock trades at 38.8× trailing-twelve-month earnings and 1.3× sales; its P/E is higher than 62% of its own readings over the past ten years.
Return on equity was 1.56% and debt-to-equity 0.47.
Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 1.59 (distress zone) for fiscal 2025.